BioPharmSignal logoBioPharmSignal

Biotech News

Treace Medical Secures Up to $175 Million in Debt Financing

Treace Medical Concepts (TMCI)Treace Medical ConceptsFinancing

New 5-Year Agreement Provides Continued Financial Strength & Flexibility PONTE VEDRA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and

Related news

FEMYFEMASYS2026-08-07 13:25 EST

Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million

ADPTAdaptive Biotechnologies2026-06-17 10:00 EST

Adaptive Biotechnologies Corporation Prices Upsized $300 Million Convertible Senior Notes Offering

EHCEncompass Health Corporation2026-08-10 20:30 EST

Encompass Health prices private offering of additional 5.875% senior notes due 2034

EHCEncompass Health Corporation2026-08-10 12:28 EST

Encompass Health announces launch of private offering of 5.875% senior notes due 2034

XAIRBeyond Air2026-07-30 11:00 EST

Beyond Air® Announces Up to $30.1 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules

IRIXIRIDEX2026-07-20 11:00 EST

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

ADPTAdaptive Biotechnologies2026-06-15 20:06 EST

Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

AEMDAethlon Medical2026-07-06 13:25 EST

Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

View all latest news

Treace Medical Concepts

Bunion and Midfoot Surgery Treace Medical Concepts develops orthopedic systems for the surgical correction of bunions and related midfoot deformities. Its products are designed to address the underlying three-dimensional alignment of the affected anatomy. Lapiplasty Platform The Lapiplasty procedure and associated instrumentation enable...

Recent company news

TMCITreace Medical Concepts2026-08-07 11:05 EST

Treace Medical Concepts Reports Second Quarter 2026 Financial Results

TMCITreace Medical Concepts2026-07-24 11:05 EST

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

TMCITreace Medical Concepts2026-06-18 11:05 EST

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

TMCITreace Medical Concepts2026-06-11 20:05 EST

Treace to Present at the Sidoti Small Cap Conference

TMCITreace Medical Concepts2026-05-08 11:05 EST

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Stock data

Close
4.34 USD
Market cap
225.11M USD
Exchange
NASDAQ
Sector
MedTech
Location
United States